Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic.
about
Telavancin, a multifunctional lipoglycopeptide, disrupts both cell wall synthesis and cell membrane integrity in methicillin-resistant Staphylococcus aureusMechanisms of resistance to bacteriocins targeting the mannose phosphotransferase systemSometimes it takes two to tango: contributions of dimerization to functions of human α-defensin HNP1 peptideThrough the looking glass, mechanistic insights from enantiomeric human defensinsFocal Targeting of the Bacterial Envelope by Antimicrobial PeptidesProtein Defense Systems against the Lantibiotic Nisin: Function of the Immunity Protein NisI and the Resistance Protein NSRAntimicrobial peptides: their role as infection-selective tracers for molecular imagingCrystal structure of the peptidyl-cysteine decarboxylase EpiD complexed with a pentapeptide substrateNMR study of mersacidin and lipid II interaction in dodecylphosphocholine micelles. Conformational changes are a key to antimicrobial activityThe First Structure of a Lantibiotic Immunity Protein, SpaI from Bacillus subtilis, Reveals a Novel FoldFunctional Determinants of Human Enteric -Defensin HD5: CRUCIAL ROLE FOR HYDROPHOBICITY AT DIMER INTERFACEThe Lantibiotic NAI-107 Binds to Bactoprenol-bound Cell Wall Precursors and Impairs Membrane FunctionsType AII lantibiotic bovicin HJ50 with a rare disulfide bond: structure, structure-activity relationships and mode of actionLantibiotic resistance.Antimicrobial lipopeptide tridecaptin A1 selectively binds to Gram-negative lipid IIBacteriocins of lactic acid bacteria: extending the familyBioengineering of the model lantibiotic nisinA harpin binding site in tobacco plasma membranes mediates activation of the pathogenesis-related gene HIN1 independent of extracellular calcium but dependent on mitogen-activated protein kinase activityImmunity to the bacteriocin sublancin 168 Is determined by the SunI (YolF) protein of Bacillus subtilisAn in vitro study on the effects of nisin on the antibacterial activities of 18 antibiotics against Enterococcus faecalisA bioengineered nisin derivative to control biofilms of Staphylococcus pseudintermediusTowards Development of Small Molecule Lipid II Inhibitors as Novel AntibioticsCytokeratins mediate epithelial innate defense through their antimicrobial properties.Molecular characterization of lantibiotic-synthesizing enzyme EpiD reveals a function for bacterial Dfp proteins in coenzyme A biosynthesis.Production of dehydroamino acid-containing peptides by Lactococcus lactis.Structural analysis and characterization of lacticin Q, a novel bacteriocin belonging to a new family of unmodified bacteriocins of gram-positive bacteria.Transcriptome analysis of the responses of Staphylococcus aureus to antimicrobial peptides and characterization of the roles of vraDE and vraSR in antimicrobial resistance.Response of Bacillus cereus ATCC 14579 to challenges with sublethal concentrations of enterocin AS-48.Generic and specific adaptive responses of Streptococcus pneumoniae to challenge with three distinct antimicrobial peptides, bacitracin, LL-37, and nisin.Insights into the mode of action of the two-peptide lantibiotic haloduracinIncreased ATPase activity is responsible for acid sensitivity of nisin-resistant Listeria monocytogenes ATCC 700302.A genomic approach highlights common and diverse effects and determinants of susceptibility on the yeast Saccharomyces cerevisiae exposed to distinct antimicrobial peptides.Expression and functional analysis of the subtilin immunity genes spaIFEG in the subtilin-sensitive host Bacillus subtilis MO1099Impact of genomics on the field of probiotic research: historical perspectives to modern paradigms.Nano-engineering the Antimicrobial Spectrum of Lantibiotics: Activity of Nisin against Gram Negative Bacteria.Sequential actions of the two component peptides of the lantibiotic lacticin 3147 explain its antimicrobial activity at nanomolar concentrations.Nisin resistance of Streptococcus bovisClass II antimicrobial peptides from lactic acid bacteria.Guanidino groups greatly enhance the action of antimicrobial peptidomimetics against bacterial cytoplasmic membranesThe LisRK signal transduction system determines the sensitivity of Listeria monocytogenes to nisin and cephalosporins.
P2860
Q24556635-A0672C8D-01A9-4B86-9255-B403C119B29FQ24602510-640A7F95-3C4F-48F9-B69D-74B5E7F56032Q24613395-12F626F1-2E11-44D2-9E99-4A9969F59C4EQ24652382-AE87712F-3446-4A64-AB1F-91F0EB7879F8Q26744785-FAF30362-3906-42B4-807A-64288F35CCD9Q26752597-C71535D7-0871-409A-9B3C-47B8297D4C9CQ27014021-E545AE48-3C30-47BD-A237-7362E2DAB78BQ27628731-618E8496-CD0A-4B6B-98B2-0281BEFEDB68Q27640413-9BF8B930-15BF-4F2C-B475-39795C09BF89Q27671593-CC41C3B6-6E88-4368-901E-017081E7541EQ27678985-0D2A1CFD-AE3D-4E84-A6BC-773BBA33984CQ27682197-53E8E63B-8C0E-45AA-AE57-FDD9F79688B1Q27690184-6B9B5A4B-2EDD-4D14-8619-0AF972ACAD06Q27692563-BB44E449-1635-47C8-9340-B8A850759B41Q27728149-EEEDABC2-4565-4DDF-8A56-1FF619C1428FQ28074011-9780E9DB-6F70-45A7-A435-489EAF895FCCQ28087616-642010C1-129E-4AA3-BCAF-25108586BA65Q28364429-4BD8C373-1BDF-491B-9778-E95C1911FC6DQ28488914-68CDA4DC-C8AA-4C7A-8B63-0387108C8F11Q28539984-5D49B79D-55A9-4DDD-99A6-A1FB64721FE0Q28544703-DE99CA2F-5ABE-40EF-BA87-814443554095Q28552923-2136BB04-DF27-4705-994A-DC0E030EF937Q29871126-815C1F3B-B7E3-48A1-BC41-796DC9C41CADQ30605299-6328395A-CBE6-41AF-972A-18E7ECC2522EQ33270794-76AE2F26-5B54-41A0-8FD4-11891A75B38CQ33277818-62877282-ED2D-4D42-B1ED-82176DF9B79FQ33502861-17A4E83C-A721-443F-87E8-CA3CF32B80BDQ33513315-83A22450-F8E8-4C9E-BC20-2A7652029C3DQ33516049-BD05F2AC-C5DD-4132-B22D-60FEAE3828DEQ33616867-CB7309BB-57B2-40EA-A19B-63473C976360Q33707504-33E81029-088D-4300-80A4-63974B03BB28Q33747075-9131FF0A-6EED-41A6-B140-0E1A2C2115CEQ33758602-DCB2528A-5281-4DEE-9057-6F060BAE7483Q33780331-44912DF8-37B5-4C9B-AE35-74CA33A34020Q33849047-DAB9CA63-1E90-462D-B70E-1A1611A657E7Q33883664-F31336BE-21B5-434E-8A19-CCB342739BB4Q33988904-112B1588-90BC-440B-AE76-E901FE12F55FQ33994632-C77EAE87-0F80-40DB-8EF5-BFFAFCDBBD39Q34017067-03A631A2-66A7-49A5-8AB3-EC99378EAD87Q34112145-C66C12EA-2035-4E72-B2FF-47DB98770F79
P2860
Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic.
@en
Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic.
@nl
type
label
Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic.
@en
Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic.
@nl
prefLabel
Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic.
@en
Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic.
@nl
P2093
P1433
P1476
Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic.
@en
P2093
B de Kruijff
C van Kraaij
E Breukink
I Wiedemann
O P Kuipers
P304
P356
10.1126/SCIENCE.286.5448.2361
P407
P577
1999-12-01T00:00:00Z